Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Board withdraws quality‑assurance rulemaking to reconsider after new medication‑error law
Summary
The board voted to withdraw its pending rulemaking to amend Title 16 §1711 on quality assurance programs and to refer development of new text to the enforcement and compounding committee, delegating early drafting to two board members.
The California State Board of Pharmacy voted to withdraw a pending rulemaking package amending Title 16, section 1711, the board said, to allow staff and members time to reconsider the proposed text in light of recent statutory changes and upcoming implementation of Assembly Bill 1286.
Board President Seung Oh said the board’s formal rulemaking process had not begun until August 9, 2024, despite initial board approval in February 2023, and that the one‑year deadline for the rulemaking approach required the board to act to preserve options. Staff recommended withdrawal of the current rulemaking so members could reassess whether the previously proposed language remains appropriate…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
